Latest Breaking News On - Xeris biopharma daily - Page 1 : comparemela.com

Xeris Biopharma s (XERS) Overweight Rating Reaffirmed at Piper Sandler

Xeris Biopharma s (XERS) Overweight Rating Reaffirmed at Piper Sandler
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesXeris biopharmaPiper sandlerVanguard group incXeris biopharma holdings incChina universal asset management coPrincipal financial group incFree reportGet free reportFinancial groupUniversal asset managementBiopharma holdingsXeris biopharma daily

Xeris Biopharma (NASDAQ:XERS) Posts Earnings Results, Misses Expectations By $0 02 EPS

Xeris Biopharma (NASDAQ:XERS) Posts Earnings Results, Misses Expectations By $0 02 EPS
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

United statesPiper sandlerXeris biopharmaPrincipal financial group incXeris biopharma holdings incVanguard group incChina universal asset management coGet free reportBiopharma trading downFinancial groupUniversal asset managementBiopharma holdingsXeris biopharma daily

Xeris Biopharma (XERS) Set to Announce Quarterly Earnings on Thursday

Xeris Biopharma (XERS) Set to Announce Quarterly Earnings on Thursday
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesXeris biopharmaXeris biopharma company profileXeris biopharma holdings incGet free reportBiopharma stock downBiopharma holdingsXeris biopharma daily

Xeris Biopharma (NASDAQ:XERS) Research Coverage Started at Oppenheimer

Oppenheimer initiated coverage on shares of Xeris Biopharma (NASDAQ:XERS – Free Report) in a research report report published on Thursday morning, Marketbeat reports. The firm issued an outperform rating and a $5.00 target price on the stock. Separately, HC Wainwright upped their target price on shares of Xeris Biopharma from $5.50 to $6.00 and gave […]

United statesXeris biopharmaVanguard group incXeris biopharma holdings incBarclays plcGoldman sachs group incCapital partnersFree reportGet free reportSachs groupBiopharma holdingsXeris biopharma dailyNasdaq xersInitiated coverageOppenheimer holdings inc

Research Analysts Issue Forecasts for Xeris Biopharma Holdings, Inc s Q1 2024 Earnings (NASDAQ:XERS)

Research Analysts Issue Forecasts for Xeris Biopharma Holdings, Inc s Q1 2024 Earnings (NASDAQ:XERS)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesXeris biopharmaBlackrock incStonepine capital managementVanguard group incGeode capital managementXeris biopharma holdings incXeris biopharma holdingsFree reportGet free reportBiopharma stock downCapital managementBiopharma holdingsXeris biopharma daily